Novartis Shareholder Calls for Board Shakeup After Major Clinical Trial Setbacks
Macro·3 articles across 3 outlets·↩ Updated
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Novartis AG shareholder Artisan Partners has called for a shakeup of the company's board and an improvement in its dealmaking strategy. This demand follows a significant decline in Novartis shares after three major clinical trial setbacks.
The investor's call for change comes as the Swiss drugmaker's stock suffered a record fall, highlighting the urgent need for a revamp in leadership and strategy to regain investor confidence.
NovartisArtisan Partners
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Novartis AG shareholder Artisan Partners said the Swiss drugmaker needs to shake up its board and improve dealmaking after its shares plunged following three major clinical trial setbacks, Reuters”
Bloomberg — Novartis Needs Board Shakeup and M&A Revamp, Investor Says“Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks”
Yahoo Finance — Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks“A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks”
stat news — STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
Earlier versions
- Sep 10, 11:50 AM — Novartis Needs Board Shakeup and M&A Revamp After Shareholder Concerns (1/1)